Sionna Therapeutics (SION) Free Cash Flow (2024 - 2026)
Sionna Therapeutics (SION) posted Free Cash Flow of -$21.8 million for Q1 2026, down 29.77% sequentially from -$16.8 million in Q4 2025, and down 33.38% YoY from -$32.8 million in Q1 2025.
Sionna Therapeutics (SION) Free Cash Flow (2024 - 2026) Analysis & Trends
Sionna Therapeutics has reported Free Cash Flow for 3 years, with the latest figure at -$21.8 million in Q1 2026.
- Quarterly Free Cash Flow fell 33.38% year-over-year to -$21.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$72.1 million (down 28.79% YoY) and the FY2025 annual result came in at -$66.7 million, down 26.24% from the prior year.
- Free Cash Flow declined to -$21.8 million in Q1 2026 per SION's latest filing, from -$16.8 million in the prior quarter.
- Over five years, Free Cash Flow peaked at -$10.1 million in Q2 2024 and troughed at -$21.8 million in Q1 2026.
- A 3-year average of -$15.7 million and a median of -$16.4 million in 2025 frame the typical range for Free Cash Flow.
- The widest YoY moves for Free Cash Flow: up 13.39% in 2025, down 78.94% in 2025.
- Over 3 years, Free Cash Flow stood at -$11.8 million in 2024, then sank by 42.53% to -$16.8 million in 2025, then declined by 29.77% to -$21.8 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$21.8 million, -$16.8 million, and -$15.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -389.61 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 437.80 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2.33 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 477.44 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 292.04 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -95.09 Mn |
| 10 | Sionna Therapeutics | 291.76 Mn | 291.76 Mn | - | -22.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -22.22 Mn |
| Jun 30, 2026 | -22.22 Mn |
| Mar 31, 2026 | -21.84 Mn |
| Mar 31, 2026 | -21.84 Mn |
| Dec 31, 2025 | -16.83 Mn |
| Dec 31, 2025 | -16.83 Mn |
| Sep 30, 2025 | -15.32 Mn |
| Sep 30, 2025 | -15.32 Mn |
| Jun 30, 2025 | -18.15 Mn |
| Jun 30, 2025 | -18.15 Mn |
| Mar 31, 2025 | -16.37 Mn |
| Mar 31, 2025 | -16.37 Mn |
| Dec 31, 2024 | -11.81 Mn |
| Dec 31, 2024 | -11.81 Mn |
| Sep 30, 2024 | -17.69 Mn |
| Sep 30, 2024 | -17.69 Mn |
| Jun 30, 2024 | -10.15 Mn |
| Jun 30, 2024 | -10.15 Mn |
| Mar 31, 2024 | -13.18 Mn |
| Mar 31, 2024 | -13.18 Mn |